|
12 Sep 2025 |
Mold-Tek Packaging
|
Consensus Share Price Target
|
824.80 |
957.67 |
- |
16.11 |
buy
|
|
|
|
|
29 Jul 2022
|
Mold-Tek Packaging
|
ICICI Direct
|
824.80
|
935.00
|
823.05
(0.21%)
|
Target met |
Hold
|
|
|
|
|
27 Jul 2022
|
Mold-Tek Packaging
|
Prabhudas Lilladhar
|
824.80
|
830.00
|
815.45
(1.15%)
|
Target met |
Accumulate
|
|
|
|
|
31 May 2022
|
Mold-Tek Packaging
|
Geojit BNP Paribas
|
824.80
|
799.00
|
720.70
(14.44%)
|
Target met |
Accumulate
|
|
|
|
|
12 May 2022
|
Mold-Tek Packaging
|
Axis Direct
|
824.80
|
777.00
|
683.30
(20.71%)
|
Target met |
Buy
|
|
|
Maintain BUY with a TP of Rs 777/share (earlier Rs 755/share) valuing it at ~24x PE its FY24E.
|
|
10 May 2022
|
Mold-Tek Packaging
|
ICICI Direct
|
824.80
|
750.00
|
694.00
(18.85%)
|
Target met |
Hold
|
|
|
|
|
09 May 2022
|
Mold-Tek Packaging
|
Prabhudas Lilladhar
|
824.80
|
781.00
|
694.00
(18.85%)
|
Target met |
Buy
|
|
|
|
|
31 Jan 2022
|
Mold-Tek Packaging
|
Geojit BNP Paribas
|
824.80
|
827.00
|
723.80
(13.95%)
|
Target met |
Accumulate
|
|
|
Overall volumes declined by 4% YoY due to lower off-take from Paints, Lubes segments & F&F segments. EBITDA grew by 14% & EBITDA/kg grew by 19% YoY to Rs.43.1....
|
|
28 Jan 2022
|
Mold-Tek Packaging
|
Axis Direct
|
824.80
|
920.00
|
714.05
(15.51%)
|
Target met |
Buy
|
|
|
We revise our FY22 estimates downward, while increasing the FY23/24 estimates on the back of strong earnings visibility. Retain BUY with a TP of Rs 920/share valuing it at 23x PE its FY24E.
|
|
03 Nov 2021
|
Mold-Tek Packaging
|
Geojit BNP Paribas
|
824.80
|
793.00
|
726.65
(13.51%)
|
Target met |
Accumulate
|
|
|
Growth to gain further momentum in H2FY22E on account of festive and higher volumes from F&F.; Focus on value added products, capacity expansion, backward integration, strong client addition in F&F; segment & strong growth momentum in paints segments, instills confidence. We roll forward to FY24E and value MTEP at a P/E of 21x on...
|
|
02 Nov 2021
|
Mold-Tek Packaging
|
IDBI Capital
|
824.80
|
667.00
|
717.15
(15.01%)
|
Target met |
Hold
|
|
|
Healthy net sales growth led by higher volume and improved NSR MPL reported 8% YoY increase in sales volume to 6,468MT. The management guided that the company witnessed better realization of capacities particularly in new plants. IML in value terms is 62% in Q2FY22 compared to 66% Q2FY21. Sales growth from...
|